OrthoPediatrics Corp. to Report First Quarter Financial Results on April 30, 2026
Rhea-AI Summary
OrthoPediatrics (Nasdaq: KIDS) will report first quarter 2026 financial results on Thursday, April 30, 2026 after market close and will host a conference call the same day at 4:30 p.m. ET.
According to the company, a live and archived webcast will be available on the Investors page at www.orthopediatrics.com, with replay access for at least 90 days.
Positive
- None.
Negative
- None.
News Market Reaction – KIDS
In the Apr 17 session, KIDS gained 1.33%, reflecting a mild positive market reaction. Argus tracked a trough of -2.7% from its starting point during tracking. Our momentum scanner triggered 16 alerts that day, indicating notable trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Earnings date Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Feb 12 | Earnings date set | Neutral | +1.0% | Announced timing and call details for Q4 and full-year 2025 results. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Limited tag-specific history: the last earnings-date announcement saw a modest +1.02% move the next day.
This announcement sets the timing for OrthoPediatrics’ Q1 2026 results, similar to the prior earnings-date release on Feb 12, 2026 that preceded the strong Q4/FY 2025 earnings report with record revenue and improved profitability metrics. That earlier scheduling headline was followed by a modest +1.02% move, indicating that date-setting releases have historically had a low but positive impact, with the substantive reaction coming on the actual earnings report.
AI-generated analysis. How Rhea-AI works. Not financial advice.
WARSAW, Ind., April 16, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its first quarter 2026 financial results on Thursday, April 30, 2026 after the market closes. OrthoPediatrics will host a conference call on Thursday, April 30, 2026 at 4:30 p.m. ET to discuss the results.
Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at www.orthopediatrics.com, on the Investors page in the Events & Presentations section. The webcast will be available for replay for at least 90 days after the event.
About OrthoPediatrics Corp.
Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such, it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets over 85 products that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and over 75 countries outside the United States. For more information, please visit www.orthopediatrics.com. For more information about the OrthoPediatrics Specialty Bracing portfolio, please visit www.opsb.com.
Investor Contact
Philip Trip Taylor
Gilmartin Group
philip@gilmartinir.com
415-937-5406
